Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Cost of Revenue (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Cost of Revenue over the past 3 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $1.1 million for Q4 2025, down 10.57% from a year ago — trailing twelve months through Dec 2025 was $6.6 million (down 14.49% YoY), and the annual figure for FY2025 was $6.6 million, down 14.49%.
  • Cost of Revenue for Q4 2025 was $1.1 million at Tonix Pharmaceuticals Holding, down from $1.4 million in the prior quarter.
  • Over the last five years, Cost of Revenue for TNXP hit a ceiling of $3.4 million in Q2 2024 and a floor of $943000.0 in Q1 2025.
  • Median Cost of Revenue over the past 3 years was $1.6 million (2024), compared with a mean of $1.9 million.
  • Biggest five-year swings in Cost of Revenue: crashed 50.02% in 2024 and later decreased 2.82% in 2025.
  • Tonix Pharmaceuticals Holding's Cost of Revenue stood at $2.4 million in 2023, then crashed by 50.02% to $1.2 million in 2024, then decreased by 10.57% to $1.1 million in 2025.
  • The last three reported values for Cost of Revenue were $1.1 million (Q4 2025), $1.4 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.